| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_029116ee41eeec8a03f88a8cddbaa758 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-378 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
| filingDate |
2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a400a73a765a0a0bbb8d71b51942d69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c37bd2a7e29a8d39178dc680ec0f6c91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49fe3468c4230dacf2bf945f06fa4563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a14416ef342d29c45f15eee8deb9c66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5609ec5ed3e76d95d3ebc64728c97af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32411c2f7c53f8d4824b62a6f8a7e4c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd0be59c71dbd3bf5337fc3ff020531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aa53182bd02d4332372f8b394958a7d |
| publicationDate |
2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020330757-A1 |
| titleOfInvention |
Systems for administering electrical stimulation to treat cancer |
| abstract |
Embodiments herein relate to a medical device for treating a cancerous tumor, including an electric field generating circuit configured to generate one or more electric fields at or near a site of the cancerous tumor and control circuitry in communication with the electric field generating circuit. The medical device includes one or more supply wires in electrical communication with the electric field generating circuit and one or more supply electrodes. The supply electrodes are configured to deliver an electric field at or near the site of the cancerous tumor. The medical device can include one or more sensing wires in electrical communication with the control circuitry and one or more sensing electrodes. The sensing electrodes can be configured to measure an impedance of the cancerous tumor at at least two different electric field strengths. Other embodiments are also included herein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022147153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11338135-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11691006-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023063626-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607542-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607543-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471676-B2 |
| priorityDate |
2019-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |